Upgrade to SI Premium - Free Trial

Vanda Pharmaceuticals (VNDA) PT Lowered to $21 at H.C. Wainwright

May 11, 2026 6:59 AM
(Updated - May 11, 2026 7:13 AM EDT)

H.C. Wainwright analyst Raghuram Selvaraju lowered the price target on Vanda ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change